These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29488212)

  • 1. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
    Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
    Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.
    Xia B; He Q; Pan Y; Gao F; Liu A; Tang Y; Chong C; Teoh AYB; Li F; He Y; Zhang C; Yuan J
    Int J Cancer; 2020 Dec; 147(12):3384-3393. PubMed ID: 32580250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
    Dibaba DT; Ogunsina K; Braithwaite D; Akinyemiju T
    Breast Cancer Res Treat; 2019 Feb; 174(1):209-218. PubMed ID: 30465158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: The Japan Multi-Institutional Collaborative Cohort (J-MICC) study.
    Nguyen TV; Arisawa K; Katsuura-Kamano S; Ishizu M; Nagayoshi M; Okada R; Hishida A; Tamura T; Hara M; Tanaka K; Nishimoto D; Shibuya K; Koyama T; Watanabe I; Suzuki S; Nishiyama T; Kuriki K; Nakamura Y; Saito Y; Ikezaki H; Otonari J; N Koyanagi Y; Matsuo K; Mikami H; Kusakabe M; Takeuchi K; Wakai K
    PLoS One; 2022; 17(7):e0269550. PubMed ID: 35802721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative.
    Chlebowski RT; Aragaki AK; Pan K; Simon MS; Neuhouser ML; Haque R; Rohan TE; Wactawski-Wende J; Orchard TS; Mortimer JE; Lane D; Kaunitz AM; Desai P; Wild RA; Barac A; Manson JE
    Cancer; 2024 Sep; 130(18):3147-3156. PubMed ID: 38736319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of weight-adjusted waist index with cardiovascular disease and mortality among metabolic syndrome population.
    Tao Z; Zuo P; Ma G
    Sci Rep; 2024 Aug; 14(1):18684. PubMed ID: 39134613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location.
    Jin EH; Han K; Lee DH; Shin CM; Lim JH; Choi YJ; Yoon K
    Gastroenterology; 2022 Sep; 163(3):637-648.e2. PubMed ID: 35643169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and the risk of severe cancer events: a longitudinal study in Japanese workers.
    Van Hoang D; Inoue Y; Fukunaga A; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Yamamoto M; Miyamoto T; Gommori N; Kochi T; Shirasaka T; Eguchi M; Ogasawara T; Yamamoto K; Konishi M; Katayama N; Kabe I; Dohi S; Mizoue T
    BMC Cancer; 2023 Jun; 23(1):555. PubMed ID: 37328825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women.
    Park B
    J Gynecol Oncol; 2022 Jul; 33(4):e35. PubMed ID: 35320886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of metabolic syndrome score trajectory patterns with risk of all cancer types.
    Deng L; Liu T; Liu CA; Zhang Q; Song MM; Lin SQ; Wang YM; Zhang QS; Shi HP
    Cancer; 2024 Jun; 130(12):2150-2159. PubMed ID: 38462898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study.
    Arthur RS; Kabat GC; Kim MY; Wild RA; Shadyab AH; Wactawski-Wende J; Ho GYF; Reeves KW; Kuller LH; Luo J; Beebe-Dimmer J; Simon MS; Strickler H; Wassertheil-Smoller S; Rohan TE
    Cancer Causes Control; 2019 Apr; 30(4):355-363. PubMed ID: 30788634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.
    Gathirua-Mwangi WG; Monahan PO; Murage MJ; Zhang J
    Cancer Causes Control; 2017 Feb; 28(2):127-136. PubMed ID: 28097473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
    Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
    Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
    Xia B; Peng J; Enrico T; Lu K; Cheung EC; Kuo Z; He Q; Tang Y; Liu A; Fan D; Zhang C; He Y; Pan Y; Yuan J
    BMC Cancer; 2021 Oct; 21(1):1084. PubMed ID: 34620113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies.
    Osadnik K; Osadnik T; Gierlotka M; Windak A; Tomasik T; Mastej M; Kuras A; Jóźwiak K; Penson PE; Lip GYH; Mikhailidis DP; Toth PP; Catapano AL; Ray KK; Howard G; Tomaszewski M; Charchar FJ; Sattar N; Williams B; MacDonald TM; Banach M; Jóźwiak J
    Eur J Prev Cardiol; 2023 Sep; 30(12):1195-1204. PubMed ID: 37039119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin, C-reactive protein, and cancer mortality in the NHANES III.
    Wulaningsih W; Holmberg L; Ng T; Rohrmann S; Van Hemelrijck M
    Cancer Med; 2016 Jan; 5(1):120-8. PubMed ID: 26632325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
    Song M; Liu T; Liu H; Zhang Q; Zhang Q; Wang Y; Ma X; Cao L; Shi H
    BMC Cancer; 2022 Aug; 22(1):853. PubMed ID: 35927639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and outcomes following early-stage breast cancer.
    Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
    Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome, its components, and mortality in the elderly.
    Akbaraly TN; Kivimaki M; Ancelin ML; Barberger-Gateau P; Mura T; Tzourio C; Touchon J; Ritchie K; Berr C
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E327-32. PubMed ID: 20810578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study.
    Hosseinpanah F; Nazeri P; Ghareh S; Tohidi M; Azizi F
    Eur J Clin Nutr; 2014 Mar; 68(3):295-9. PubMed ID: 23963276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.